作者
Ferran Nadeu,Romina Royo,Ramon Massoni-Badosa,Heribert Playà-Albinyana,Beatriz García-Torre,Martí Duran‐Ferrer,Kevin J. Dawson,Marta Kulis,Ander Díaz‐Navarro,Neus Villamor,Juan L. Melero,Vicente Chapaprieta,Ana Dueso-Barroso,Julio Delgado,Riccardo Moia,Sara Ruiz-Gil,Doménica Marchese,Ariadna Giró,Núria Verdaguer-Dot,Mònica Romo,Guillem Clot,Marı́a Rozman,Gerard Frigola,Alfredo Rivas‐Delgado,Tycho Baumann,Miguel Alcoceba,Marcos González,Fina Climent,Pau Abrisqueta,Josep Castellví,Francesc Bosch,Marta Aymerich,Anna Enjuanes,Sílvia Ruiz-Gaspà,Armando López‐Guillermo,Pedro Jares,Sı́lvia Beà,Salvador Capella-Gutiérrez,Josep Lluís Gelpí,Núria López‐Bigas,David Torrents,Peter J. Campbell,Marta Gut,Davide Rossi,Gianluca Gaïdano,Xosé S. Puente,Pablo M. García-Rovés,Dolors Colomer,Holger Heyn,Francesco Maura,José I. Martín‐Subero,Elı́as Campo
摘要
Abstract Richter transformation (RT) is a paradigmatic evolution of chronic lymphocytic leukemia (CLL) into a very aggressive large B cell lymphoma conferring a dismal prognosis. The mechanisms driving RT remain largely unknown. We characterized the whole genome, epigenome and transcriptome, combined with single-cell DNA/RNA-sequencing analyses and functional experiments, of 19 cases of CLL developing RT. Studying 54 longitudinal samples covering up to 19 years of disease course, we uncovered minute subclones carrying genomic, immunogenetic and transcriptomic features of RT cells already at CLL diagnosis, which were dormant for up to 19 years before transformation. We also identified new driver alterations, discovered a new mutational signature (SBS-RT), recognized an oxidative phosphorylation (OXPHOS) high –B cell receptor (BCR) low -signaling transcriptional axis in RT and showed that OXPHOS inhibition reduces the proliferation of RT cells. These findings demonstrate the early seeding of subclones driving advanced stages of cancer evolution and uncover potential therapeutic targets for RT.